GO	[-5.47 -0.71]	[-0.71 -0.36]	[-0.36 -0.19]	[-0.19 -0.05]	[-0.05 0.00]	[0.00 0.00]	[0.00 0.10]	[0.10 0.28]	[0.28 0.55]	[0.55 1.06]	[1.06 7.81]
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-0.813	20.004	9.013	1.507	-2.331	-5.731	-0.634	-1.578	-3.355	-5.731	-5.713
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	0.693	15.917	6.581	2.414	-3.060	-4.638	-1.608	-2.485	-1.608	-5.817	-5.801
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	0.406	6.992	9.630	6.509	-2.599	-6.693	-0.543	-1.755	-3.765	-5.456	-4.506
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-1.779	20.915	4.268	2.212	-3.165	-5.496	-0.310	-0.722	-3.165	-4.559	-3.151
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-0.613	17.011	6.807	0.735	-2.351	-4.900	-0.443	-1.432	-1.843	-4.900	-4.886
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	0.791	12.760	5.588	2.827	-1.590	-6.401	-1.960	-0.339	-4.267	-4.267	-5.166
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-0.294	9.587	10.116	1.559	-4.170	-6.718	-0.506	0.309	-3.561	-2.167	-4.152
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-3.437	9.389	5.615	3.362	-0.946	-7.863	-0.263	0.567	-1.168	-3.437	-4.717
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-0.324	15.755	3.403	1.542	-4.026	-4.026	-0.324	-2.264	-1.709	-4.026	-2.255
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-0.975	17.877	5.720	1.016	-2.852	-5.105	-1.234	-1.234	-2.341	-1.909	-1.898
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	0.691	17.733	3.657	1.412	-4.070	-3.468	-2.094	-1.186	-1.747	-2.946	-2.081
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	0.319	14.830	3.829	1.832	-2.228	-6.151	-1.807	-0.697	-1.153	-2.728	-3.312
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	1.118	13.326	4.856	0.601	-5.653	-3.291	-2.277	-0.992	-2.277	0.260	-3.920
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-1.192	5.475	3.539	7.290	-0.458	-7.361	-0.761	-0.959	0.462	-3.645	-6.066
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	1.293	13.657	6.226	-0.432	-2.385	-3.939	-1.997	-1.114	-0.898	-2.831	-2.372
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	0.985	9.449	6.369	2.474	-3.196	-3.833	-3.196	-1.182	-1.804	-1.804	-2.644
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	0.755	11.907	5.320	1.190	-2.947	-3.752	-1.815	-2.319	-1.815	-1.408	-2.309
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-0.388	15.132	4.757	0.610	-2.043	-3.227	-1.609	-0.963	-2.573	-3.227	-0.956
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	0.301	13.927	3.807	0.636	-2.510	-2.510	-2.510	-0.458	-1.836	-3.485	-1.828
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	0.301	12.858	4.990	0.816	-1.650	-2.919	-2.197	-1.227	-1.650	-2.197	-2.910
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	0.620	13.150	5.429	0.620	-2.359	-3.906	-0.882	-2.359	-1.973	-1.637	-1.626
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	0.500	11.277	4.961	0.849	-1.957	-5.067	-1.533	-0.677	-1.533	-3.122	-1.524
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-1.260	3.160	5.744	2.555	-2.192	-8.072	1.321	0.944	-0.517	-3.061	-3.576
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-1.053	11.635	4.006	1.565	-2.658	-2.658	-0.751	-1.053	-3.652	-1.448	-1.047
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-0.608	7.611	6.633	2.078	-0.608	-3.291	-0.782	-0.992	-0.992	-2.745	-5.635
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	0.342	9.818	6.892	-0.264	-1.999	-2.903	-1.999	-0.961	-1.393	-1.999	-1.992
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-0.771	13.306	1.665	2.709	-3.183	-3.183	-1.858	-1.051	-2.432	-0.553	-1.045
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.327	-0.898	-2.831	-0.432	-2.831	-1.997	-2.831	-0.714	-0.432	6.673	11.329
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	3.320	10.205	2.960	-2.576	-3.159	-3.159	-0.817	-0.465	-0.623	-1.054	-2.564
KRIGE_AMINO_ACID_DEPRIVATION KRIGE_AMINO_ACID_DEPRIVATION	18.561	-1.202	-1.202	-1.202	-0.610	-1.202	-1.202	-1.202	-1.202	0.572	-0.608
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-3.253	1.584	3.620	3.975	-1.594	-6.322	0.514	1.825	0.799	-1.308	-5.316
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	0.276	9.919	4.971	1.162	-2.224	-3.867	-0.957	-0.328	-2.224	-1.201	-3.214
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	1.843	11.696	3.242	0.692	-1.654	-3.236	-2.342	-1.130	-1.654	-2.342	-1.363
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	0.970	11.232	2.474	-0.301	-1.712	-2.571	-0.301	-1.152	-1.712	-2.571	-2.564
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	0.884	-1.474	-4.085	-2.256	-2.759	0.708	-1.832	-0.292	-1.173	3.042	11.453
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-2.359	1.769	1.769	3.881	-1.637	-6.401	0.932	4.246	-0.548	-1.347	-4.577
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	0.724	11.349	1.555	0.353	-1.225	-3.319	-0.255	-0.596	-0.865	-3.319	-3.310
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	1.231	11.481	2.602	0.539	-1.477	-2.696	-1.477	-1.477	-2.696	-1.999	-1.072
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-0.366	3.577	10.500	0.828	-1.985	-3.982	-1.558	-1.985	0.486	-2.509	-0.917
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	0.330	1.666	10.325	0.763	-2.365	-5.650	0.954	-0.703	-0.703	-1.899	-2.354
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-0.521	-2.001	-1.646	-4.108	-1.646	-0.395	-2.001	-0.395	1.431	2.484	11.609
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-2.256	2.456	8.242	0.795	-2.256	-4.775	0.610	0.795	-0.567	-1.034	-2.867
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	0.329	8.658	3.881	0.923	-1.429	-4.910	-1.429	0.445	-0.886	-2.698	-1.771
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-0.610	6.341	5.838	0.881	-1.063	-3.404	0.395	0.282	-1.369	-3.404	-3.391
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	0.416	11.781	2.015	0.245	-2.280	-1.466	-0.600	-0.949	-0.949	-2.280	-2.274
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-0.302	9.506	2.850	1.765	-1.028	-3.592	-0.517	0.301	-1.528	-3.061	-3.046
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-0.316	8.834	2.690	1.364	-1.362	-2.156	-0.865	-0.535	-2.156	-2.156	-2.150
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	0.635	-0.659	-3.061	-3.592	2.555	8.991	-0.659	-2.597	-1.028	-1.528	2.291
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-0.391	10.443	2.119	2.119	-2.065	-2.770	-1.127	-0.812	-2.065	-1.127	-1.527
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-1.278	2.813	3.444	5.277	-1.860	-6.797	-0.408	0.926	-1.045	-1.549	-1.269
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-0.993	5.784	3.116	2.209	-1.230	-5.186	1.242	-0.270	-0.993	-3.132	-2.191
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	1.150	9.318	0.597	1.377	-2.667	-6.067	-0.503	-0.667	-0.503	-0.869	-1.398
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-1.288	-1.572	-1.901	0.815	-3.223	-5.298	-0.660	0.987	4.783	3.322	1.867
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-2.397	1.178	1.649	2.199	-3.527	-5.183	0.974	3.906	0.791	-1.590	-1.949
EPPERT_PROGENITOR EPPERT_PROGENITOR	1.120	5.272	3.968	0.912	-2.425	-5.734	0.310	-0.959	-0.735	-1.559	-1.550
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-2.862	-0.626	-0.626	1.029	0.357	-2.862	8.445	2.484	-1.963	-1.363	-0.930
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-1.933	-0.338	-1.420	4.080	-0.731	-3.610	3.596	2.312	1.023	-2.621	-1.926
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	0.344	10.893	2.242	-0.262	-3.677	-3.102	-0.468	-0.976	-0.262	-1.211	-0.968
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-3.284	0.293	3.928	3.239	0.293	-7.654	0.633	0.633	0.389	-0.310	-2.320
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	0.435	8.479	3.053	0.435	-2.239	-2.239	-0.578	-1.431	-1.431	-0.921	-1.426
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	0.251	4.779	3.023	2.284	-1.261	-4.609	-0.508	0.367	-0.703	-1.649	-3.512
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-3.426	-0.743	-0.310	-1.214	-2.821	-5.066	0.399	1.484	2.621	2.307	3.324
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-0.287	9.722	2.540	-0.287	-1.122	-2.529	0.315	-1.677	-0.738	-1.677	-1.671
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-0.422	8.301	4.412	-0.264	-0.647	-1.999	-0.647	-0.961	-0.961	-1.393	-2.895
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	0.359	0.359	7.294	1.197	-0.478	-5.984	0.359	0.985	-0.834	-1.362	-3.179
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	0.910	6.045	2.473	1.232	-2.280	-2.280	-0.949	-0.600	-2.280	-0.949	-1.461
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-2.021	0.736	0.593	5.315	-0.728	-4.665	2.507	1.962	-0.442	-2.860	-2.008
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-2.705	0.721	1.234	3.006	-4.336	-5.896	-0.437	2.421	1.660	-0.334	-0.432
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-1.045	2.557	4.688	2.261	-1.301	-7.027	-0.277	0.434	-0.375	-1.301	-1.292
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	1.840	-2.250	-3.260	-2.715	0.480	0.268	-1.852	-0.594	-0.975	4.505	4.937
LE_EGR2_TARGETS_UP LE_EGR2_TARGETS_UP	-0.493	10.736	1.991	0.905	-2.101	-2.705	-0.930	-1.237	-0.930	-0.930	-0.680
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-1.355	1.164	2.813	4.602	-0.733	-4.151	0.921	0.524	-0.521	-3.107	-2.356
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-1.807	-0.976	0.884	2.835	-0.976	-6.125	3.157	1.971	1.065	-0.468	-3.087
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	-0.335	-1.386	-3.971	-0.914	-1.132	-0.572	-3.376	0.593	0.896	4.912	5.342
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	12.480	0.357	-0.626	-1.363	-1.963	-2.862	-0.626	-0.252	0.357	-0.406	-0.622
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	1.029	8.445	1.681	-0.252	-2.862	-2.862	-0.935	-0.406	-0.626	-0.935	-1.357
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-1.027	0.574	-1.926	-1.027	-2.804	-5.731	-0.366	0.889	3.961	2.014	2.610
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-0.320	4.634	4.210	0.676	-2.034	-3.796	1.051	-0.442	-0.320	-2.034	-3.080
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	0.283	9.217	1.516	1.516	-1.016	-2.034	0.283	-3.093	-1.016	-2.034	-1.008
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-2.962	0.320	1.635	6.817	-0.940	-4.522	0.438	1.144	0.438	-0.719	-2.384
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-0.291	0.593	0.439	2.771	-3.714	-4.817	1.218	2.412	1.218	-1.787	-2.278
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	2.076	-1.787	-2.288	-2.288	3.986	3.986	-0.291	-3.714	-1.055	-0.418	0.598
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.782	7.108	1.040	3.486	-1.057	-1.782	-1.057	-0.624	-1.057	-1.057	-1.053
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.332	10.380	1.319	0.455	-2.197	-2.197	-0.556	-0.556	-0.893	-0.893	-1.392
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-0.867	5.146	6.110	0.255	-1.439	-4.367	-0.352	-0.486	0.361	-1.439	-1.431
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	2.714	-2.051	-4.177	-1.691	0.976	2.714	-1.691	-1.691	0.292	-0.545	4.496
HELLER_SILENCED_BY_METHYLATION_DN HELLER_SILENCED_BY_METHYLATION_DN	13.305	-0.869	-1.540	-0.869	-2.009	-1.540	-0.634	-0.312	0.290	-0.451	0.581
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-0.318	6.633	1.129	3.082	-0.991	-0.991	-0.991	-0.991	-1.699	-1.699	-1.695
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-0.774	0.322	3.617	2.820	-1.034	-4.775	-1.034	3.207	-0.405	-0.567	-2.867
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-0.490	-0.652	-2.145	-3.940	-1.731	0.612	-0.851	-0.490	-0.258	7.740	3.242
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	0.270	5.116	3.321	1.439	-0.889	-5.896	-0.334	-0.334	-0.562	-1.095	-2.691
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.302	-0.829	-1.837	-1.528	-2.192	-4.203	-1.028	1.765	2.275	2.850	3.848
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-3.689	-1.953	-0.292	0.727	-0.292	-2.425	5.272	4.819	-0.407	-0.959	-0.729
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.552	-2.605	-2.072	-0.744	-1.277	-0.744	-1.635	0.445	0.321	6.143	5.178
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	0.412	4.438	2.096	2.501	-0.775	-3.153	-0.523	-0.523	-0.775	-1.580	-3.144
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	0.814	4.742	3.492	0.546	-2.031	-2.031	-1.259	-0.472	-0.472	-1.259	-2.026
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-3.223	0.987	4.395	2.685	-0.660	-4.490	0.309	-0.293	0.987	-0.392	-2.704
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.431	8.062	1.620	0.370	-0.729	-1.948	0.370	-1.191	-0.431	-1.948	-1.943
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-0.732	7.434	3.283	0.485	-3.580	-2.101	0.276	-0.570	0.276	-1.424	-1.146
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-1.225	-2.363	-0.397	0.353	-3.319	-2.363	-0.865	3.136	3.608	1.902	0.356
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-2.473	0.657	2.946	4.926	-1.803	-2.473	1.439	-0.289	-1.803	-0.442	-1.302
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-0.391	9.727	1.168	0.349	-1.127	-3.776	-0.812	-0.258	-0.812	-1.127	-0.568
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-0.392	8.023	1.832	0.568	-1.452	-3.326	-1.153	0.568	-0.284	-2.728	-0.691
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-1.099	1.998	1.998	3.865	-1.099	-2.982	0.291	1.417	-0.443	-3.790	-1.834
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	0.542	7.650	2.373	0.721	-2.071	-1.595	-0.668	-0.668	-0.479	-2.671	-1.586
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	0.597	3.102	5.698	-0.431	-0.729	-1.948	-0.729	0.370	-1.948	-1.191	-1.943
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-1.452	1.568	0.319	6.477	-1.153	-3.326	0.568	1.568	-0.697	-0.528	-3.312
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	0.359	4.050	3.166	2.028	-2.399	-3.145	-0.373	-0.537	-0.537	-1.029	-2.389
LENAOUR_DENDRITIC_CELL_MATURATION_DN LENAOUR_DENDRITIC_CELL_MATURATION_DN	-1.392	-2.766	-1.392	1.067	-3.439	-1.766	-0.331	0.677	1.830	1.553	4.395
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-1.706	-1.706	-1.706	-2.606	-1.074	-0.834	-0.638	1.963	1.687	1.431	5.823
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-0.228	9.127	1.271	0.625	-0.702	-1.158	-1.158	-1.158	-0.702	-1.907	-1.153
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	0.499	1.592	7.452	-0.438	-0.986	-2.945	-2.035	-0.276	0.499	-0.986	-1.418
WIELAND_UP_BY_HBV_INFECTION WIELAND_UP_BY_HBV_INFECTION	-1.460	-1.460	-0.810	-1.097	-1.460	-1.097	-2.500	1.309	0.827	4.315	4.333
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	1.379	-3.653	-1.209	-2.962	1.144	3.240	-0.940	-1.209	-1.209	1.144	2.550
ZHAN_MULTIPLE_MYELOMA_CD1_UP ZHAN_MULTIPLE_MYELOMA_CD1_UP	10.996	-0.228	-0.411	-0.702	-1.158	-1.907	-1.158	-0.228	-0.411	-1.158	0.391
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-0.385	7.315	2.092	0.453	-0.733	-1.367	-1.367	-0.385	-0.733	-1.367	-1.364
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-2.152	-0.595	2.002	5.475	-2.578	-3.072	-0.595	1.507	0.590	0.590	-1.456
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	-0.596	-1.707	-2.363	-0.865	-1.225	0.520	-0.865	-0.596	-0.397	2.282	8.395
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	-0.569	-0.398	-3.220	-0.790	1.080	6.482	-0.569	-3.220	-1.074	0.648	1.349
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	0.870	-1.164	-0.885	-2.445	-2.445	0.515	-0.483	-0.483	-0.885	0.870	8.865
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-1.254	2.045	2.368	0.990	-0.963	-4.059	-0.273	3.878	-1.254	-2.043	-0.721
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	0.790	1.062	5.189	2.119	-1.927	-1.927	-0.910	-0.606	-0.390	-0.910	-2.812
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	-0.533	0.301	-3.483	-2.026	1.191	7.166	0.301	-1.669	-1.362	0.301	1.201
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-0.479	5.428	3.130	0.928	-0.909	-3.447	-0.668	0.392	-0.668	-1.214	-2.061
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-2.982	-1.136	0.497	0.632	-1.136	-5.967	0.382	2.677	2.096	0.497	1.157
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	1.695	-1.321	-0.285	-0.845	-1.623	-0.385	-1.976	-2.386	-0.662	5.906	2.848
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	1.702	1.405	-0.373	1.136	-1.029	-4.192	-1.029	4.529	-0.537	-1.828	-1.023
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-1.803	-1.803	-1.308	-1.308	-0.442	-1.803	-0.934	0.467	2.130	3.880	3.413
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-1.966	-0.351	2.263	1.264	-0.522	-3.652	1.565	0.759	1.899	-1.448	-2.649
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	1.097	0.551	3.519	1.846	-1.252	-5.775	0.414	0.301	-1.252	0.301	-1.970
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	0.576	-0.505	-1.933	-1.933	0.404	6.884	-0.731	-1.933	-1.420	-0.338	2.324
LUI_THYROID_CANCER_PAX8_PPARG_DN LUI_THYROID_CANCER_PAX8_PPARG_DN	-0.702	-1.907	1.677	0.625	-1.907	-1.907	0.625	2.640	2.134	-0.702	-1.901
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-1.540	-0.869	-0.312	2.114	-1.167	-4.442	0.290	3.665	2.464	-0.312	-1.160
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-1.093	-3.226	-0.360	-0.851	-2.145	-2.637	0.964	3.597	2.872	1.173	0.474
BROWNE_INTERFERON_RESPONSIVE_GENES BROWNE_INTERFERON_RESPONSIVE_GENES	-0.885	-0.586	-0.586	-0.885	-1.891	-2.779	-1.891	0.818	2.609	2.609	2.619
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-0.711	0.419	1.644	4.672	-1.392	-3.568	-0.326	1.644	-0.489	-0.489	-2.575
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-1.367	-0.898	-1.114	0.479	-1.367	-1.659	-2.385	-0.560	2.842	4.966	2.274
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-0.621	-1.556	-1.901	-1.556	-1.901	-1.261	-0.475	1.097	0.907	2.330	6.128
SCHLOSSER_SERUM_RESPONSE_UP SCHLOSSER_SERUM_RESPONSE_UP	-0.412	-2.637	-0.292	-1.003	-1.003	-3.298	2.982	1.410	4.626	-0.761	-0.288
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-0.851	1.173	-0.360	1.930	-0.652	-6.025	0.612	3.225	-0.490	0.469	-2.134
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-1.424	0.276	1.333	0.372	-3.580	-6.007	1.333	1.559	0.938	1.126	-0.323
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	0.541	5.545	2.676	-0.260	-0.691	-2.446	0.346	-1.606	-0.691	-1.606	-1.059
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	0.646	-0.545	-2.468	-4.964	0.292	0.392	-1.382	-0.545	0.801	1.612	4.897
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	0.783	3.700	2.514	0.285	-0.318	-1.699	-0.991	-1.699	-1.699	0.501	-1.695
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-1.051	-2.432	-1.858	-0.553	-0.771	-3.183	0.667	1.108	3.534	2.709	0.672
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-0.503	6.135	1.150	1.150	-1.406	-4.871	0.338	-0.667	0.338	-0.667	-1.105
EGUCHI_CELL_CYCLE_RB1_TARGETS EGUCHI_CELL_CYCLE_RB1_TARGETS	0.217	9.398	0.490	-0.911	-0.406	-0.911	-0.406	-0.911	-0.406	-0.911	-0.909
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-1.211	-1.783	0.274	1.928	-0.527	-2.654	0.906	2.808	2.349	-1.211	-1.777
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	3.695	-1.316	-2.678	-1.078	-0.873	-1.316	-1.316	0.473	-0.551	1.686	4.428
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-0.348	5.480	0.944	1.652	-0.921	-2.239	-0.578	0.435	-0.578	-1.431	-2.233
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-0.961	-0.422	2.872	3.867	-1.393	-2.903	2.012	-0.422	-0.422	-0.961	-1.387
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-1.133	-0.682	0.742	2.786	-0.275	-4.910	-0.515	3.132	0.742	0.445	-2.685
BURTON_ADIPOGENESIS_PEAK_AT_16HR BURTON_ADIPOGENESIS_PEAK_AT_16HR	0.749	6.463	2.432	-0.599	-0.599	-1.024	-0.599	-1.024	-1.024	-1.024	-1.736
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-1.171	1.024	-0.369	-0.820	-2.290	-3.236	-1.171	0.381	1.313	4.814	0.777
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-0.844	-1.860	-0.672	2.244	-3.090	-4.236	0.386	1.104	1.510	1.983	0.935
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	0.946	2.867	2.477	0.728	-1.329	-4.109	-0.984	1.194	-0.984	-0.984	-1.322
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	-0.810	-1.408	-2.947	-1.077	-1.408	-1.077	-0.810	1.447	3.102	2.037	2.738
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	0.430	2.807	5.388	-0.373	-1.090	-1.090	-0.650	0.239	-0.650	-1.824	-1.819
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	0.301	-1.815	-1.077	-0.810	-2.319	-2.319	0.577	0.577	-0.430	3.102	4.855
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	1.850	-0.354	-3.122	-0.496	-1.957	-0.677	-1.957	-0.496	0.254	1.850	4.982
KOBAYASHI_EGFR_SIGNALING_24HR_UP KOBAYASHI_EGFR_SIGNALING_24HR_UP	0.667	-0.771	-0.771	-1.858	-4.234	-0.553	-1.051	-0.260	2.709	3.109	1.381
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	0.513	-1.909	-0.436	-0.759	-3.460	-3.460	0.388	1.457	0.513	2.911	2.285
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-1.706	2.261	2.915	0.628	-0.834	-3.193	1.431	0.628	0.628	-1.706	-2.594
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-0.278	3.955	1.812	-0.278	-1.771	-3.402	1.812	0.326	-0.633	-1.771	-0.906
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	0.524	5.110	2.071	0.371	-0.360	-4.151	-1.006	0.249	-0.360	-1.355	-1.348
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.276	1.961	2.806	2.806	-0.986	-2.945	-0.986	-0.276	0.328	-2.035	-1.418
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-2.863	1.035	1.035	1.695	-1.976	-4.853	0.690	1.695	1.035	-0.845	-0.281
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	0.395	0.395	-3.165	-1.779	-1.446	-0.722	-0.722	-0.722	0.517	3.162	5.113
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-0.451	5.560	1.565	1.180	-0.755	-1.990	-0.256	-0.451	-0.755	-1.225	-1.984
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	-1.211	-1.211	-1.783	-0.810	-1.211	0.440	-0.810	-0.527	0.274	2.808	6.297
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	0.559	-1.654	-0.264	1.193	-1.654	-5.124	1.610	1.610	1.610	0.842	-1.962
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	0.391	-1.016	0.283	-1.016	-0.784	-4.677	-1.016	-0.320	0.522	3.805	3.436
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.301	5.977	1.112	0.856	-0.958	-2.510	-1.336	1.112	-1.336	-0.672	-1.329
GAURNIER_PSMD4_TARGETS GAURNIER_PSMD4_TARGETS	0.328	-2.035	-1.424	-2.035	-0.986	-0.438	-0.668	0.328	-0.276	5.489	2.818
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	1.545	-0.580	-1.608	-3.761	-0.767	2.414	-0.311	-3.060	0.693	1.813	1.082
VALK_AML_CLUSTER_5 VALK_AML_CLUSTER_5	-1.326	-1.326	-0.702	-1.326	-1.326	-1.326	0.247	0.793	1.184	2.177	2.779
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	0.372	-0.390	-0.910	-1.927	-0.910	-1.927	-1.332	-0.390	1.728	0.560	6.483
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-1.302	3.079	3.079	1.416	-0.374	-2.779	0.581	-0.586	-0.885	-1.302	-1.296
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.385	0.453	5.553	1.577	-1.367	-1.367	0.231	-0.733	0.231	-1.367	-1.364
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	0.997	2.425	4.988	0.519	-0.961	-1.393	-0.422	-1.393	-0.647	-1.393	-1.992
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	3.400	-1.832	-1.173	0.554	-2.256	-4.085	0.554	0.884	-0.292	1.800	0.559
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	0.871	-2.358	-1.301	-3.387	0.706	0.434	-0.498	-1.301	0.327	1.259	5.125
LY_AGING_OLD_DN LY_AGING_OLD_DN	-0.622	5.239	3.993	-0.622	-0.622	-1.501	0.233	-0.977	-0.977	-0.382	-1.496
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-1.393	-0.422	2.425	1.636	-1.393	-1.999	0.342	3.867	-0.264	-0.961	-1.992
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN	0.735	-1.432	-0.829	-3.790	-0.829	1.417	-0.613	-1.099	-0.312	1.417	4.785
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-0.312	-0.443	0.936	3.050	-1.843	-3.790	0.936	1.417	1.163	-1.843	-1.424
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	0.370	2.842	1.094	0.479	-1.997	-4.630	-1.367	0.914	-1.659	1.741	0.374
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-1.787	-0.582	-2.913	-1.055	-1.055	-1.787	0.593	1.765	3.154	2.076	0.781
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	1.856	-0.614	0.339	2.230	-1.739	-3.360	0.339	3.071	-0.614	-0.888	-1.247
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-0.412	0.432	1.679	1.166	-1.299	-4.136	0.749	2.982	0.432	-1.003	-2.626
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	-0.638	-0.834	-1.362	-4.793	0.257	0.359	0.482	-0.638	0.628	0.795	5.823
STEARMAN_TUMOR_FIELD_EFFECT_UP STEARMAN_TUMOR_FIELD_EFFECT_UP	-1.533	-0.860	-0.860	-0.860	-0.250	-0.860	-0.860	-0.250	0.614	0.359	8.318
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-1.253	1.516	4.554	1.516	-2.400	-2.400	-0.614	0.339	-0.266	-1.253	-0.264
CUI_GLUCOSE_DEPRIVATION CUI_GLUCOSE_DEPRIVATION	2.540	0.315	-1.122	-0.738	-2.529	-2.529	-0.738	1.689	2.540	-0.287	-0.285
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-2.306	1.219	2.663	2.663	-0.671	-2.864	-0.885	1.219	0.477	-0.671	-1.836
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	1.277	4.189	1.596	0.538	-1.198	-2.326	0.748	-1.675	-0.842	-0.842	-1.668
SANA_RESPONSE_TO_IFNG_UP SANA_RESPONSE_TO_IFNG_UP	0.642	-1.517	-2.144	-1.064	-1.064	-1.517	-0.488	-0.488	1.815	4.613	1.474
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.981	-0.981	-0.473	-2.547	-1.868	-0.691	-0.981	2.034	0.615	2.034	3.751
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	1.166	0.578	-0.761	-1.299	-3.298	-2.101	-0.566	-0.566	-0.292	2.982	3.379
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-1.431	-0.578	0.435	0.944	0.435	-0.921	5.480	0.944	-1.431	-0.921	-2.233
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-0.228	1.677	1.677	0.625	-0.411	-1.907	2.640	-0.411	-1.158	-1.907	-1.901
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	0.445	1.815	5.187	-0.488	-1.064	-3.070	-0.314	0.288	0.288	-1.064	-1.511
LIU_COMMON_CANCER_GENES LIU_COMMON_CANCER_GENES	-1.211	1.928	0.440	0.651	-1.211	-2.654	1.546	0.651	1.546	-2.654	-0.806
FRASOR_RESPONSE_TO_ESTRADIOL_DN FRASOR_RESPONSE_TO_ESTRADIOL_DN	1.313	-0.820	-0.820	-2.290	-1.171	-1.171	-1.643	0.558	0.243	4.814	1.646
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	-0.744	-1.635	-0.282	-3.263	-0.400	-0.552	-0.400	-0.400	0.768	0.594	7.231
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	-0.888	-0.888	-0.614	0.502	-2.400	-2.400	-0.888	-0.266	1.209	3.071	3.084
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	-0.668	-0.986	-2.035	-0.438	-0.668	-2.945	0.966	2.366	3.786	-0.276	0.330
DELPUECH_FOXO3_TARGETS_DN DELPUECH_FOXO3_TARGETS_DN	4.494	2.069	1.176	-0.300	-0.549	-1.658	-0.958	-1.658	-0.958	-0.549	-0.546
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	2.122	3.181	1.037	-0.510	-2.509	-3.157	-0.694	-0.255	1.272	-0.694	-1.201
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-1.393	-0.422	0.997	4.988	-0.422	-1.999	0.342	1.636	-0.264	-1.393	-1.992
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	1.255	4.831	0.997	0.279	-2.264	-2.994	0.279	-0.940	-1.278	0.412	-0.472
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-0.869	0.290	1.491	2.464	-0.869	-2.603	0.576	1.789	0.976	-2.603	-2.000
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-1.144	2.046	1.680	1.350	0.798	-2.253	1.680	-0.797	-0.797	-1.612	-2.245
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP	8.983	-1.005	-1.392	-0.489	0.278	-0.326	-0.326	-0.489	-1.901	-0.326	0.280
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	-1.508	-0.506	-1.508	1.559	-1.815	-4.170	0.962	1.792	1.792	1.144	0.313
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-0.373	5.388	2.277	0.430	-1.090	-1.824	0.239	-1.090	-0.650	-0.650	-1.086
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	3.690	-0.885	0.515	-2.445	-0.885	0.515	-1.164	-0.483	-1.508	-0.483	4.135
MOSERLE_IFNA_RESPONSE MOSERLE_IFNA_RESPONSE	-1.326	-0.702	-0.702	0.247	-1.326	-1.326	-1.326	2.771	2.771	0.793	0.482
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-0.276	-2.065	-0.276	-0.506	-2.065	-1.684	-0.856	-0.276	0.439	2.994	4.924
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	0.301	-0.525	-1.062	-0.851	-2.307	-3.840	-0.402	1.825	1.361	3.280	0.977
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-0.731	-1.029	-0.505	0.576	-0.731	-3.610	3.596	2.712	0.782	-0.731	-0.726
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-2.597	0.781	1.124	2.012	-0.659	-5.746	0.396	0.635	0.781	0.781	-0.821
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-1.294	1.095	3.991	1.461	-0.810	-2.073	0.781	0.317	-0.810	-1.294	-1.289
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.262	0.344	-0.468	-0.776	-2.178	-2.606	-0.776	-0.468	-0.354	3.494	4.626
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-1.792	3.894	1.796	1.796	-1.416	-2.798	0.372	0.504	-0.849	-0.849	-0.635
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	0.309	0.519	-0.389	-1.815	-3.561	-2.167	-0.647	-0.294	1.559	2.307	2.905
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	7.591	-0.828	-0.453	-0.453	-1.492	-0.234	-0.453	-1.492	-0.234	-0.453	0.649
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3	1.512	-0.765	-1.409	-1.409	1.079	0.716	-1.409	-0.765	-1.409	0.716	2.579
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	-0.264	-0.919	0.442	0.559	-0.586	-5.971	-0.351	1.843	1.009	2.636	-1.363
FURUKAWA_DUSP6_TARGETS_PCI35_DN FURUKAWA_DUSP6_TARGETS_PCI35_DN	-0.454	8.024	0.936	0.314	-1.012	-1.455	-0.288	-1.012	-1.012	-1.012	-0.286
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-0.301	4.008	3.461	0.301	-1.152	-2.571	-0.301	-0.489	-1.152	-0.489	-0.758
NAKAMURA_CANCER_MICROENVIRONMENT_DN NAKAMURA_CANCER_MICROENVIRONMENT_DN	2.204	2.722	0.958	0.409	-0.392	-1.865	-0.676	0.409	-0.676	-1.865	-1.860
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	0.991	-3.265	0.991	0.826	-1.393	-3.811	-0.468	0.547	3.203	0.547	-0.355
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	1.191	-0.983	-2.072	-2.605	1.440	2.008	-0.744	-1.635	-0.983	1.440	1.723
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	1.435	-0.903	-0.512	-1.872	-1.872	0.782	-0.265	-0.687	-1.167	-0.265	6.487
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	1.706	3.135	0.980	1.319	-1.397	-2.197	-0.893	-0.893	0.272	-0.893	-1.392
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	0.339	-0.614	-1.253	-0.266	-2.400	-3.360	0.339	0.937	2.635	-0.266	2.240
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	1.971	-0.608	-0.608	-1.211	-2.606	-3.102	-0.776	0.451	2.242	1.971	1.074
TANG_SENESCENCE_TP53_TARGETS_DN TANG_SENESCENCE_TP53_TARGETS_DN	0.397	5.239	2.405	-0.622	-0.622	-2.322	-0.382	-0.382	-0.622	-0.977	-0.973
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-0.904	0.433	2.420	1.103	0.433	-4.949	1.103	1.325	-0.528	-0.904	-1.797
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-3.236	-0.586	1.610	2.092	-1.373	-3.236	1.843	0.692	0.842	-0.586	-0.261
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.865	-1.225	-1.225	-0.255	-1.707	-2.363	-0.596	1.555	0.965	2.282	2.705
SIMBULAN_PARP1_TARGETS_DN SIMBULAN_PARP1_TARGETS_DN	-0.704	5.288	1.206	-0.704	-0.272	-0.704	0.706	-0.704	-0.704	-0.704	-0.702
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-0.527	4.395	0.651	1.546	-1.211	-2.654	0.274	-0.329	0.440	-1.783	-0.806
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-1.868	0.289	-0.981	1.366	-1.364	-3.527	-0.473	2.034	1.366	1.366	0.292
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-0.636	2.130	0.934	1.851	-0.482	-2.012	-0.823	1.851	0.756	-2.976	-2.001
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.546	-1.241	3.226	2.740	-1.241	-2.696	0.262	1.168	-0.344	-0.546	-0.831
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	2.046	-0.541	-1.612	-0.541	-3.194	-0.541	-0.355	-0.541	-0.541	3.338	1.689
GREENBAUM_E2A_TARGETS_UP GREENBAUM_E2A_TARGETS_UP	0.754	3.306	2.092	0.754	-1.367	-1.367	-1.367	-0.733	-0.733	-0.385	-0.730
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 MIKKELSEN_MEF_LCP_WITH_H3K4ME3	-0.301	-0.778	-1.322	-1.687	-1.687	-0.778	-0.581	0.301	0.420	2.934	5.040
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	0.416	-0.531	-1.731	-0.399	-2.117	-3.102	-0.531	1.046	0.858	3.984	1.264
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	0.326	-1.280	-1.280	-1.771	-0.278	-0.278	-1.280	-0.911	0.484	1.812	5.603
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.035	-0.416	3.806	1.112	-1.571	-2.405	0.362	1.844	-0.668	-0.247	-1.030
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-1.756	2.187	1.150	3.547	-1.113	-2.172	0.597	-0.503	0.597	-1.756	-0.862
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	-1.261	0.367	0.367	1.644	-0.703	-2.132	0.511	3.856	0.367	0.251	-3.512
KERLEY_RESPONSE_TO_CISPLATIN_UP KERLEY_RESPONSE_TO_CISPLATIN_UP	0.409	-1.124	-0.676	-1.124	-1.865	-0.392	-0.676	-1.124	0.958	2.722	3.298
SMID_BREAST_CANCER_LUMINAL_A_UP SMID_BREAST_CANCER_LUMINAL_A_UP	3.267	-1.364	-1.868	-0.981	-0.981	0.831	0.615	-2.547	0.289	0.435	2.044
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.430	-0.311	-0.580	-0.311	-1.608	-4.638	-0.767	0.403	1.813	2.414	1.825
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-0.364	2.602	3.463	1.528	0.246	-1.999	-0.538	-1.077	-0.771	-1.999	-0.766
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	-0.926	3.629	-0.732	1.559	-1.424	-2.101	-2.523	0.617	0.276	1.803	-0.323
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-1.858	-0.301	-0.413	2.998	-1.497	-2.790	-0.728	-0.301	2.998	1.275	-0.298
GALE_APL_WITH_FLT3_MUTATED_UP GALE_APL_WITH_FLT3_MUTATED_UP	-0.691	-0.260	1.791	3.716	-1.064	-2.446	1.411	-0.434	-0.434	-0.434	-1.601
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	1.856	-2.400	-0.614	-2.400	1.516	-0.412	-0.888	-1.253	0.701	0.339	2.647
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	-0.301	1.190	2.037	2.368	0.301	-2.947	0.301	-1.815	-0.810	-2.319	0.761
HOLLERN_EMT_BREAST_TUMOR_UP HOLLERN_EMT_BREAST_TUMOR_UP	0.693	-0.996	-1.608	0.291	-1.274	-3.060	-0.996	0.291	2.103	1.545	2.761
MACAEVA_PBMC_RESPONSE_TO_IR MACAEVA_PBMC_RESPONSE_TO_IR	-1.460	-0.585	-1.460	-0.810	-1.097	-1.918	-0.585	1.593	1.593	3.413	1.318
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	-0.310	-0.844	-0.672	-1.045	-1.045	-1.278	-1.045	-0.528	0.293	3.782	4.908
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-0.992	0.344	0.645	2.199	-2.194	-3.599	0.344	2.547	0.837	-0.537	-0.732
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-1.933	-0.505	0.782	1.943	-1.420	-3.610	0.782	1.604	0.576	0.576	-0.726
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-1.383	0.439	0.439	5.395	-1.787	-2.913	0.439	0.593	0.439	-0.418	-0.577
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	1.509	-0.872	-0.678	-0.872	-0.678	2.029	-3.070	-1.707	0.428	0.428	3.313
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	0.749	5.567	0.578	-0.292	-1.661	-2.637	0.432	-0.412	-0.292	-0.292	-1.652
VILIMAS_NOTCH1_TARGETS_DN VILIMAS_NOTCH1_TARGETS_DN	-1.119	-0.550	-0.550	-1.119	0.347	-1.119	-0.550	0.347	1.503	-0.550	4.960
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	1.356	4.160	0.873	-0.406	-0.911	-0.911	-0.911	0.217	-0.406	-0.911	-0.909
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-1.034	-0.405	-0.774	0.795	-1.358	-2.878	1.007	1.246	4.502	-0.567	-0.562
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	0.906	-0.329	-0.810	-1.211	-0.527	-0.810	-1.211	-0.329	-1.783	3.302	3.315
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-0.813	2.295	1.076	2.295	-1.926	-3.355	-0.634	0.445	0.889	-0.269	-1.272
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	1.151	0.379	-1.536	-1.006	-1.006	-0.235	-1.536	-0.645	-1.006	1.900	3.911
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-1.855	2.231	-0.566	0.846	-0.359	-2.737	2.673	0.405	0.405	-0.860	-0.855
MUELLER_METHYLATED_IN_GLIOBLASTOMA MUELLER_METHYLATED_IN_GLIOBLASTOMA	0.453	-1.782	-0.354	-1.782	0.254	3.486	-1.057	-0.354	-1.057	0.453	1.869
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-1.029	1.136	1.405	-0.373	-0.752	-3.145	0.507	1.702	1.702	-0.537	-2.389
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-0.284	-0.284	-1.153	-0.697	-1.153	-4.049	0.725	1.568	-0.697	2.116	2.129
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	1.087	0.265	-1.580	-0.775	-0.523	3.408	-0.775	-3.153	0.412	1.387	-0.338
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-0.949	1.601	1.232	1.601	-1.466	-1.466	1.232	0.637	-0.949	-0.365	-2.274
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	3.392	4.241	0.281	-1.872	-0.456	-1.120	0.281	-0.456	-0.629	-1.120	-0.842
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	-0.234	0.646	5.060	0.646	-1.492	-0.828	0.380	-0.828	-0.828	-1.492	-0.233
COLDREN_GEFITINIB_RESISTANCE_UP COLDREN_GEFITINIB_RESISTANCE_UP	0.419	2.768	1.052	1.644	-1.392	-2.584	0.806	-0.326	-0.489	-1.901	-0.999
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	0.612	1.957	-0.382	1.551	-2.322	-1.501	0.233	0.233	1.190	-0.382	-2.315
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	1.653	-0.875	-1.201	-0.432	-0.624	-0.875	-1.621	-1.201	-0.290	1.985	4.078
THILLAINADESAN_ZNF217_TARGETS_UP THILLAINADESAN_ZNF217_TARGETS_UP	0.783	1.997	1.129	1.129	-1.699	-1.699	-0.991	-0.574	0.501	0.285	-1.695
QI_HYPOXIA QI_HYPOXIA	2.092	-0.342	0.372	0.372	-3.475	-1.792	-0.849	0.840	-0.342	3.111	-0.842
IGLESIAS_E2F_TARGETS_UP IGLESIAS_E2F_TARGETS_UP	-1.093	0.348	-0.652	-1.093	-1.093	-1.731	-1.384	1.173	0.612	1.173	4.846
SANA_TNF_SIGNALING_UP SANA_TNF_SIGNALING_UP	-0.301	-1.336	-1.336	-0.458	-1.336	-0.672	-1.836	0.451	1.402	3.332	2.092
WARTERS_IR_RESPONSE_5GY WARTERS_IR_RESPONSE_5GY	0.334	-2.031	-0.782	-0.472	-2.031	-1.259	0.334	0.334	1.137	1.137	2.939
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-0.921	-0.274	-0.274	3.675	-0.921	-4.483	0.595	1.406	0.330	0.330	-0.697
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-1.354	2.671	1.028	0.859	-1.952	-3.748	0.263	1.214	0.350	0.571	-0.896
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	0.629	4.801	0.827	1.053	-1.918	-1.460	-0.280	-0.411	-1.918	-0.585	-0.580
BEIER_GLIOMA_STEM_CELL_DN BEIER_GLIOMA_STEM_CELL_DN	0.604	-1.271	-0.860	0.405	-2.737	-1.855	-0.359	1.132	0.250	1.132	2.684
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	6.742	0.362	-0.247	-0.247	-0.663	-0.663	-0.663	-0.247	-0.247	-0.663	-0.661
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-0.792	0.593	4.435	1.218	-0.792	-2.288	1.218	-0.291	-0.582	-1.383	-1.049
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	-0.247	-0.663	-0.663	-0.663	1.292	2.696	1.939	-0.663	-0.663	-0.663	-0.661
JIANG_AGING_HYPOTHALAMUS_DN JIANG_AGING_HYPOTHALAMUS_DN	-0.430	-1.450	-0.430	0.403	-1.450	-0.430	0.403	6.032	-0.219	-0.796	-0.217
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-1.241	1.560	1.330	1.118	0.601	-3.936	0.601	1.330	-1.534	-0.992	-0.602
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN	1.320	-0.676	-1.124	0.226	-0.392	-0.676	-1.124	-1.865	-0.392	1.320	3.910
BIDUS_METASTASIS_DN BIDUS_METASTASIS_DN	-1.960	-1.011	0.791	0.266	-1.960	-2.914	2.199	0.629	0.487	1.403	0.982
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	-1.152	-1.152	-1.152	0.478	-0.301	-1.712	-0.762	0.301	0.970	0.478	5.221
RICKMAN_HEAD_AND_NECK_CANCER_D RICKMAN_HEAD_AND_NECK_CANCER_D	-0.266	-0.893	-0.893	-1.575	0.339	4.765	0.584	-0.893	-0.500	-0.893	1.283
WILENSKY_RESPONSE_TO_DARAPLADIB WILENSKY_RESPONSE_TO_DARAPLADIB	-1.160	-0.580	-0.580	0.324	-1.160	-1.160	-1.160	0.978	0.607	1.432	2.572
SERVITJA_LIVER_HNF1A_TARGETS_DN SERVITJA_LIVER_HNF1A_TARGETS_DN	0.615	-1.852	-0.975	-1.852	0.770	3.736	-0.975	-1.852	0.615	0.770	0.954
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	0.533	0.282	-1.739	2.168	-1.063	-4.251	-0.321	-0.321	0.282	1.583	1.099
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	0.610	-0.727	-0.538	1.470	-2.043	-4.059	-0.273	1.218	1.746	0.788	-0.533
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	0.582	-0.886	-0.682	1.126	-2.698	-4.013	0.582	0.582	0.742	1.597	0.748
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-0.489	1.644	0.806	1.988	-0.711	-3.568	1.331	0.278	-0.489	-0.711	-1.385
CHUNG_BLISTER_CYTOTOXICITY_UP CHUNG_BLISTER_CYTOTOXICITY_UP	-1.209	0.745	-0.283	2.536	-1.535	-3.653	2.214	0.580	0.320	-0.539	-0.391
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-0.310	-0.687	-1.079	-0.536	-1.615	-1.949	-0.310	0.950	-0.687	2.918	3.596
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	0.860	-0.331	-1.392	0.518	-1.766	-2.766	-0.625	-0.625	0.860	1.067	3.563
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-0.813	0.889	0.889	2.295	-2.331	-4.004	0.336	0.574	0.445	0.889	-0.806
PARK_HSC_AND_MULTIPOTENT_PROGENITORS PARK_HSC_AND_MULTIPOTENT_PROGENITORS	-0.392	0.409	1.736	1.320	-1.865	-1.124	1.320	-0.392	0.958	-1.865	-1.120
ROSS_AML_WITH_CBFB_MYH11_FUSION ROSS_AML_WITH_CBFB_MYH11_FUSION	-0.316	-0.535	-0.316	-0.316	-2.156	-1.362	-0.865	-0.316	0.476	1.017	5.065
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-1.650	1.318	1.615	0.441	-1.227	-3.943	0.441	1.052	0.441	0.441	-0.637
CASTELLANO_NRAS_TARGETS_UP CASTELLANO_NRAS_TARGETS_UP	-1.012	-0.454	-0.689	-0.454	-0.288	-2.071	-1.012	0.936	-0.454	5.386	0.941
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.400	-1.277	-2.072	-0.400	-2.605	-0.282	0.321	-0.282	3.031	2.327	0.775
BORCZUK_MALIGNANT_MESOTHELIOMA_DN BORCZUK_MALIGNANT_MESOTHELIOMA_DN	0.432	-1.514	-0.438	-1.979	-0.438	0.593	-2.568	-0.301	0.783	1.002	3.743
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	1.690	-0.363	-2.203	-1.830	-0.363	-0.270	-0.791	-1.830	0.564	1.690	2.814
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	0.906	-1.211	-0.329	-1.783	-0.527	-1.211	-0.810	0.440	-0.810	3.302	2.359
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-1.384	0.612	0.348	3.225	-0.490	-2.637	0.348	0.964	1.404	-0.652	-2.134
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	1.416	0.388	-0.586	0.238	-1.302	-2.779	-0.885	4.121	0.238	0.238	-0.372
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-0.919	1.610	3.567	-1.373	-0.351	-3.779	0.559	-0.264	0.692	-0.586	-0.347
SESTO_RESPONSE_TO_UV_C1 SESTO_RESPONSE_TO_UV_C1	-1.091	2.559	1.119	1.769	-2.180	-0.327	0.428	0.276	-1.091	0.276	-2.172
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	-0.520	-1.077	0.371	-1.077	-1.077	-0.520	-1.077	0.684	0.371	3.507	1.092
LUI_THYROID_CANCER_CLUSTER_3 LUI_THYROID_CANCER_CLUSTER_3	-0.580	-1.160	0.978	0.978	-0.580	-1.160	1.432	1.962	0.324	-1.160	-1.157
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	1.796	2.361	0.880	-0.320	-1.243	0.283	0.283	-0.320	-1.243	-1.240
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.854	-0.854	-0.854	-0.854	-1.592	-1.176	-0.606	0.472	1.692	1.692	3.674
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	-0.424	-3.333	-0.581	0.731	-1.687	-1.023	-0.424	0.301	0.923	2.246	2.259
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-1.064	-0.691	-2.446	-1.606	0.346	1.075	-0.691	-0.260	0.541	1.411	2.686
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	-0.731	-0.338	-1.029	-0.505	3.140	0.782	-0.505	-3.610	0.267	0.267	1.613
PETROVA_PROX1_TARGETS_UP PETROVA_PROX1_TARGETS_UP	2.916	2.916	0.398	-0.491	-0.491	-0.491	-0.491	-1.036	-1.036	-1.036	-0.221
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-0.475	-0.798	0.345	-0.621	-0.475	-2.304	-1.010	-0.475	1.534	5.651	-0.258
SEKI_INFLAMMATORY_RESPONSE_LPS_DN SEKI_INFLAMMATORY_RESPONSE_LPS_DN	0.490	0.490	-0.406	-0.911	-0.911	0.217	-0.911	-0.911	-0.911	1.356	3.346
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	-0.640	-1.243	-0.640	-0.320	-1.243	-1.243	0.283	1.796	-0.320	2.991	0.884
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-1.367	-0.385	2.669	0.754	-0.733	-1.367	1.577	0.754	-0.385	-0.385	-1.364
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-1.595	-0.909	1.163	1.715	0.392	-2.671	0.270	1.715	0.928	0.270	-2.061
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	1.083	-0.599	-1.741	-0.599	1.083	4.242	-0.599	-1.024	-0.336	-1.024	0.271
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	-0.222	-1.036	1.149	-0.222	-1.036	-1.036	1.658	1.658	0.726	-1.036	-1.033
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.634	0.326	-0.806	-0.806	-1.854	-3.162	0.849	0.691	1.220	0.429	3.427
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	-0.482	-0.823	-0.636	-0.636	-1.318	-2.012	-0.636	0.463	0.463	2.130	4.621
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	1.553	3.545	0.518	-0.461	-0.831	-2.218	-0.331	-1.084	-0.461	-1.766	1.307
SENESE_HDAC2_TARGETS_DN SENESE_HDAC2_TARGETS_DN	2.092	-0.849	-0.849	-0.641	-0.342	-1.416	-1.104	-1.792	0.372	2.411	2.425
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	1.234	0.270	-1.612	-0.437	-1.335	1.046	-3.177	-0.712	2.151	-0.334	1.912
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	0.445	-1.926	-1.281	-0.813	0.445	2.910	-1.281	-1.578	0.574	0.445	2.610
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-0.782	-0.472	0.334	2.929	-0.782	-2.031	0.814	0.814	0.814	-0.271	-2.026
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.987	-0.392	-1.901	-1.044	-1.288	-1.572	-0.513	0.409	-0.293	3.664	2.128
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	0.313	-0.652	-1.803	0.313	-0.652	-2.473	-0.652	0.883	0.313	0.657	4.406
MORI_PRE_BI_LYMPHOCYTE_UP MORI_PRE_BI_LYMPHOCYTE_UP	-0.266	5.104	1.209	0.701	-1.253	-0.888	0.339	-0.412	-0.888	-1.253	-1.247
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	0.451	-1.836	-0.672	-1.336	-1.336	-0.958	0.301	-0.301	0.451	2.468	3.346
SESTO_RESPONSE_TO_UV_C5 SESTO_RESPONSE_TO_UV_C5	0.625	0.389	0.920	0.920	-0.411	-1.907	0.920	1.271	-0.411	-1.907	-1.901
SASSON_RESPONSE_TO_FORSKOLIN_DN SASSON_RESPONSE_TO_FORSKOLIN_DN	-0.981	-1.364	0.831	1.366	-1.364	-2.547	-0.473	3.267	0.289	0.435	0.438
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-0.614	-1.739	-0.412	-0.614	-0.888	-1.739	0.502	1.516	4.554	0.502	-0.409
SUNG_METASTASIS_STROMA_UP SUNG_METASTASIS_STROMA_UP	0.542	-0.334	-1.595	1.163	-1.595	-2.071	0.270	-0.668	0.270	4.442	0.396
GRABARCZYK_BCL11B_TARGETS_UP GRABARCZYK_BCL11B_TARGETS_UP	-1.253	-0.266	-0.888	0.502	-0.614	-2.400	-0.614	2.635	3.071	-0.614	0.505
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	0.848	-0.755	-1.990	-1.225	-0.755	-1.225	-0.755	1.180	0.848	1.180	2.009
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-0.636	-2.012	-0.636	-0.358	-2.012	-0.636	-0.823	0.934	0.599	3.080	2.443
HOWLIN_PUBERTAL_MAMMARY_GLAND HOWLIN_PUBERTAL_MAMMARY_GLAND	-0.885	-0.586	-1.302	-1.302	1.416	-0.374	0.388	-1.891	-0.374	2.609	2.183
OKUMURA_INFLAMMATORY_RESPONSE_LPS OKUMURA_INFLAMMATORY_RESPONSE_LPS	0.849	3.755	0.551	0.326	0.326	-3.742	-1.010	-0.634	0.849	-0.373	-1.240
FINETTI_BREAST_CANCER_KINOME_RED FINETTI_BREAST_CANCER_KINOME_RED	0.762	2.696	0.762	1.292	-0.663	-0.663	-0.663	-0.663	-0.663	-0.663	-0.661
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.594	0.480	0.268	1.140	-2.715	-2.250	-1.512	0.770	0.480	0.480	3.051
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-0.893	-0.556	0.272	2.616	-0.556	-0.332	3.135	0.455	-0.893	-0.556	-2.191
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	-0.489	1.331	0.278	1.644	-0.489	-3.568	1.331	0.806	0.278	-1.005	-1.385
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	1.531	-0.924	-2.509	-0.924	0.353	-1.985	-0.366	-0.255	0.353	1.037	3.197
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-0.528	0.386	-0.844	-0.310	-1.278	-3.623	-0.844	0.926	0.622	1.983	2.538
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	0.538	-1.675	-1.675	-1.675	0.994	3.681	-0.244	-1.198	-0.244	0.538	0.542
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-1.284	0.509	1.241	2.878	-0.671	-1.284	0.836	-0.341	0.264	-0.671	-1.281
GENTILE_UV_LOW_DOSE_DN GENTILE_UV_LOW_DOSE_DN	0.651	2.808	-0.527	0.274	-0.810	-1.211	-0.329	0.440	1.928	-0.810	-2.647
CHICAS_RB1_TARGETS_LOW_SERUM CHICAS_RB1_TARGETS_LOW_SERUM	0.648	3.053	0.648	-0.270	-0.398	-1.434	-0.398	0.476	1.080	-1.434	-3.209
ONDER_CDH1_TARGETS_1_UP ONDER_CDH1_TARGETS_1_UP	0.727	-0.735	-0.959	-1.231	-0.959	-3.689	0.565	0.727	1.605	1.880	0.734
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	0.376	-0.538	-0.771	-2.696	0.246	0.246	-1.477	0.376	0.246	0.539	4.974
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.893	-0.893	-0.332	-0.332	-0.556	-2.197	-0.332	-0.556	0.980	4.295	0.985
ZHAN_V2_LATE_DIFFERENTIATION_GENES ZHAN_V2_LATE_DIFFERENTIATION_GENES	-0.392	2.722	0.958	-0.676	-0.676	-1.865	-0.676	0.409	2.204	-0.676	-1.120
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	1.082	-0.691	-1.868	-1.868	0.289	0.831	-0.313	-1.868	0.435	0.435	3.281
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-1.434	0.648	2.658	-0.790	-1.074	-3.220	-0.270	1.080	0.476	1.080	-0.395
BASSO_CD40_SIGNALING_DN BASSO_CD40_SIGNALING_DN	-0.438	-0.438	0.328	-0.668	-2.035	-2.035	-0.986	1.592	0.328	1.592	2.377
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP	1.559	0.617	-0.436	-1.155	-0.926	1.126	-2.523	-2.101	0.768	-0.327	2.359
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	0.492	-0.581	1.870	-1.490	-1.490	-2.686	1.379	0.965	-0.581	1.870	-0.576
AMIT_EGF_RESPONSE_60_HELA AMIT_EGF_RESPONSE_60_HELA	-0.729	0.370	0.370	0.597	-0.729	-1.948	-1.948	2.066	0.597	-0.729	1.627
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-0.371	-0.371	0.325	-0.278	-1.204	-4.103	0.325	3.280	1.185	0.829	-0.778
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-1.766	0.677	0.677	3.545	-0.331	-2.218	0.860	0.518	0.384	-1.084	-1.384
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT	1.213	-0.462	-0.994	-0.994	-0.994	0.426	-0.994	-0.204	-0.462	0.772	3.055
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	-0.729	0.370	0.883	3.688	-1.191	-1.948	-0.242	0.883	-1.191	-0.431	-0.240
LE_EGR2_TARGETS_DN LE_EGR2_TARGETS_DN	-0.291	-1.487	-1.949	-0.424	-2.534	-0.424	0.447	0.611	1.279	2.559	1.034
GOLUB_ALL_VS_AML_DN GOLUB_ALL_VS_AML_DN	-0.953	-0.953	0.199	0.199	-0.953	-0.953	-0.953	0.457	0.821	1.835	1.840
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-0.418	-0.418	0.892	-0.301	-0.301	-3.725	-0.751	3.913	0.414	0.710	-0.970
SCIBETTA_KDM5B_TARGETS_DN SCIBETTA_KDM5B_TARGETS_DN	0.367	2.753	1.949	0.538	-1.675	-2.326	-0.577	-0.842	0.748	-0.577	-0.573
LEE_LIVER_CANCER_ACOX1_DN LEE_LIVER_CANCER_ACOX1_DN	0.876	0.262	-1.241	-1.241	-0.344	0.422	0.422	-2.696	-0.835	1.876	1.885
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-0.566	1.825	2.673	1.132	-0.359	-0.860	-0.566	-0.359	0.250	-2.737	-0.855
WOO_LIVER_CANCER_RECURRENCE_UP WOO_LIVER_CANCER_RECURRENCE_UP	1.279	-1.120	-0.829	0.312	-1.487	-2.534	-0.829	0.611	0.447	2.559	1.287
KAMIKUBO_MYELOID_CEBPA_NETWORK KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.640	-1.243	-0.640	-0.320	-1.243	0.283	-0.320	0.539	-0.320	0.283	5.262
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-1.100	2.160	1.639	1.191	-0.877	-2.922	-0.405	1.406	-0.301	-0.877	-0.869
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	5.087	-1.003	-2.637	-0.761	0.578	-0.292	-0.761	-0.566	0.432	0.432	0.436
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	1.656	0.469	0.777	1.930	-1.093	-3.940	0.348	-0.490	0.777	-1.093	-0.646
YAGI_AML_WITH_T_9_11_TRANSLOCATION YAGI_AML_WITH_T_9_11_TRANSLOCATION	-2.218	0.677	1.553	0.518	-0.625	-4.290	-0.331	0.860	0.677	0.518	0.388
WENDT_COHESIN_TARGETS_UP WENDT_COHESIN_TARGETS_UP	-1.326	0.247	1.184	2.771	-0.363	-1.326	0.480	0.793	-0.363	-0.702	-1.322
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN	0.892	2.211	2.211	-0.199	-0.580	-0.580	-0.580	-0.580	-0.580	-0.580	-0.578
WORSCHECH_TUMOR_REJECTION_UP WORSCHECH_TUMOR_REJECTION_UP	-0.301	-1.712	-1.712	-0.762	0.478	-0.489	0.701	-1.152	0.478	0.701	4.022
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP	0.728	-2.331	-0.984	-0.506	-0.506	1.779	-1.329	-0.506	-0.714	1.472	2.490
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	0.722	-0.366	1.507	-0.634	-4.004	-2.331	0.574	0.722	-0.366	1.282	0.580
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	0.292	-0.722	-0.722	-1.446	-1.446	-0.923	-1.162	0.395	1.207	2.212	3.180
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN	-0.640	2.361	-0.320	0.539	-1.243	-1.243	0.539	1.796	-0.640	-1.243	0.284
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	-0.775	-0.341	-0.341	2.501	-3.153	-1.580	0.265	0.598	1.387	0.598	-0.338
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	0.876	1.876	-0.344	0.876	-1.241	-2.696	-1.819	1.168	-0.344	0.262	0.264
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	-0.313	0.793	-0.918	-1.680	-1.252	0.594	-0.313	-0.918	-0.918	1.024	4.421
YU_MYC_TARGETS_DN YU_MYC_TARGETS_DN	-2.446	-0.260	-0.691	-0.434	-0.434	-0.691	-0.691	-0.434	2.213	0.541	3.189
COATES_MACROPHAGE_M1_VS_M2_UP COATES_MACROPHAGE_M1_VS_M2_UP	0.419	-0.489	-0.326	0.806	-1.901	-3.568	0.806	0.278	0.419	2.363	-0.323
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	-0.316	-0.865	0.476	1.761	-1.362	-1.362	1.017	2.690	0.286	-1.362	-0.861
GAJATE_RESPONSE_TO_TRABECTEDIN_UP GAJATE_RESPONSE_TO_TRABECTEDIN_UP	1.458	0.250	0.250	-1.271	-1.855	-0.566	-0.566	-0.566	-0.860	4.210	0.607
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN	2.916	-0.491	-1.036	-1.036	-0.222	1.149	-0.222	-1.036	-1.036	0.726	0.399
GAJATE_RESPONSE_TO_TRABECTEDIN_DN GAJATE_RESPONSE_TO_TRABECTEDIN_DN	1.521	2.866	0.256	0.256	-0.828	-0.828	-0.351	-0.828	0.566	-0.828	-0.826
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	-0.310	-0.893	-0.415	3.721	-1.382	-2.468	0.646	0.646	0.292	-1.118	1.392
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	-0.316	-0.535	2.690	1.364	-1.362	-2.156	-0.865	1.364	0.286	-0.535	-0.314
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.258	0.612	-0.851	-0.360	-1.731	-3.940	0.612	2.224	-0.258	0.612	1.182
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.610	-0.610	-1.202	-0.610	-1.202	-0.610	-0.300	-0.300	1.365	1.877	2.467
MODY_HIPPOCAMPUS_PRENATAL MODY_HIPPOCAMPUS_PRENATAL	-0.650	0.239	1.798	1.370	-1.090	-1.824	2.277	0.239	-1.090	-0.650	-0.371
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-0.893	0.691	2.139	2.616	-0.332	-2.197	-0.893	0.272	-0.893	-0.556	0.274
DAUER_STAT3_TARGETS_DN DAUER_STAT3_TARGETS_DN	-0.755	-0.451	-0.755	-0.256	-1.225	-1.225	-1.225	0.351	1.180	3.588	1.185
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-0.228	1.677	3.193	0.625	-1.158	-0.702	-0.702	-0.411	-0.702	0.389	-1.901
LINDSTEDT_DENDRITIC_CELL_MATURATION_B LINDSTEDT_DENDRITIC_CELL_MATURATION_B	-0.271	-0.472	-0.271	0.546	-0.782	-2.031	-2.031	0.334	1.512	2.411	0.336
CAFFAREL_RESPONSE_TO_THC_DN CAFFAREL_RESPONSE_TO_THC_DN	-1.326	1.184	2.177	1.184	-1.326	-1.326	-0.363	-0.702	0.480	0.247	-0.361
LUI_TARGETS_OF_PAX8_PPARG_FUSION LUI_TARGETS_OF_PAX8_PPARG_FUSION	-0.765	-0.765	1.079	1.079	-0.765	-1.409	1.079	1.512	0.716	-0.765	-1.405
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	1.998	-0.465	-0.623	-1.054	0.265	-0.340	-3.159	-0.623	0.265	0.495	3.338
BOSCO_TH1_CYTOTOXIC_MODULE BOSCO_TH1_CYTOTOXIC_MODULE	1.032	-2.225	-1.334	-0.552	-1.013	0.333	-0.552	-0.552	0.628	0.628	4.130
HASLINGER_B_CLL_WITH_6Q21_DELETION HASLINGER_B_CLL_WITH_6Q21_DELETION	3.338	1.356	-0.406	0.490	-0.406	-0.911	-0.911	0.217	0.217	-0.911	-0.909
KIM_MYC_AMPLIFICATION_TARGETS_DN KIM_MYC_AMPLIFICATION_TARGETS_DN	-0.324	0.575	0.575	-0.476	-0.678	-4.026	-1.278	0.771	0.997	1.859	0.282
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	-0.373	2.229	3.250
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-2.798	0.840	0.264	0.660	-0.641	-3.475	0.660	0.840	1.522	0.372	0.267
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	2.608	-0.810	-0.810	-0.810	1.053	1.053	-0.810	-2.500	-1.097	0.827	0.833
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	0.646	-0.893	0.801	-0.545	-0.545	-4.177	-0.704	1.381	-0.310	0.392	2.428
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN	4.353	-0.355	-1.612	-1.144	0.396	0.396	-0.355	-1.612	-0.797	0.578	0.803
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-0.755	-0.755	0.351	-0.451	-1.225	-1.990	-0.755	0.571	1.565	0.848	2.493
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	-0.787	1.057	1.613	0.279	-0.324	-0.787	-0.324	2.269	-0.787	-0.787	-0.785
MEBARKI_HCC_PROGENITOR_WNT_DN MEBARKI_HCC_PROGENITOR_WNT_DN	-0.268	-0.268	-0.589	-0.833	-0.404	1.138	-2.807	-1.151	0.336	0.672	3.741
YUAN_ZNF143_PARTNERS YUAN_ZNF143_PARTNERS	-0.911	1.356	0.490	2.594	-0.406	-0.911	0.873	-0.911	-0.406	-0.911	-0.404
HARRIS_BRAIN_CANCER_PROGENITORS HARRIS_BRAIN_CANCER_PROGENITORS	0.453	-0.354	-0.624	-0.624	1.040	0.453	-1.782	-1.057	-0.354	-0.624	4.135
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-0.771	-0.364	0.967	1.856	-0.538	-3.693	0.967	0.736	0.539	-0.364	-1.072
JACKSON_DNMT1_TARGETS_UP JACKSON_DNMT1_TARGETS_UP	-0.278	0.484	0.326	1.477	-2.436	-2.436	-0.427	-0.911	0.484	2.179	0.488
DIRMEIER_LMP1_RESPONSE_LATE_UP DIRMEIER_LMP1_RESPONSE_LATE_UP	0.877	-0.977	0.397	0.233	-2.322	-2.322	0.397	1.190	0.612	1.190	-0.379
MELLMAN_TUT1_TARGETS_UP MELLMAN_TUT1_TARGETS_UP	0.256	1.521	0.256	2.148	-0.828	-0.828	-0.351	0.991	-0.828	-0.828	-0.826
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.872	0.545	0.400	2.283	-0.456	-1.872	0.716	1.661	0.545	-1.872	-0.624
EINAV_INTERFERON_SIGNATURE_IN_CANCER EINAV_INTERFERON_SIGNATURE_IN_CANCER	-1.119	-0.550	-0.260	-0.550	-1.119	-1.119	-0.550	1.032	2.052	1.503	0.647
RASHI_RESPONSE_TO_IONIZING_RADIATION_5 RASHI_RESPONSE_TO_IONIZING_RADIATION_5	0.264	2.411	0.840	0.660	-1.792	-2.798	0.264	0.372	0.840	0.372	-1.783
LIANG_SILENCED_BY_METHYLATION_UP LIANG_SILENCED_BY_METHYLATION_UP	2.092	-0.385	-1.367	-0.733	0.231	-0.385	-1.367	0.231	-0.733	0.453	2.677
WARTERS_RESPONSE_TO_IR_SKIN WARTERS_RESPONSE_TO_IR_SKIN	-0.427	0.326	-0.633	0.326	-2.436	-2.436	-0.633	0.679	1.176	1.812	1.183
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	-0.447	-0.447	0.441	1.318	-0.897	-2.919	1.942	-0.447	-0.301	-1.227	1.952
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-1.225	-0.256	0.848	0.571	-1.225	-1.990	-0.755	1.565	1.180	1.180	-0.752
GOLDRATH_IMMUNE_MEMORY GOLDRATH_IMMUNE_MEMORY	2.808	-0.329	-0.527	0.274	-1.783	-1.783	-1.211	-0.527	0.906	1.205	0.655
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	-0.663	1.292	2.696	0.762	-0.663	-0.663	-0.247	-0.663	0.362	-0.663	-0.661
BHATTACHARYA_EMBRYONIC_STEM_CELL BHATTACHARYA_EMBRYONIC_STEM_CELL	0.451	4.840	0.451	0.636	-0.958	-0.301	-0.301	-0.672	-1.836	-1.336	-0.298
PROVENZANI_METASTASIS_DN PROVENZANI_METASTASIS_DN	-1.035	0.274	-1.035	0.509	-3.126	-0.330	0.659	3.752	-0.330	-0.453	0.840
YAMASHITA_LIVER_CANCER_STEM_CELL_DN YAMASHITA_LIVER_CANCER_STEM_CELL_DN	1.724	0.412	-2.217	-1.580	0.824	0.265	-2.217	-0.341	0.265	1.087	0.829
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	-0.427	0.326	-0.911	-0.633	-0.911	-3.402	-0.278	0.909	1.477	0.909	1.485
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	0.736	-1.466	-0.761	0.261	-1.192	-0.458	-1.466	-0.345	-0.458	2.874	2.892
APRELIKOVA_BRCA1_TARGETS APRELIKOVA_BRCA1_TARGETS	1.180	-1.990	1.180	0.351	-1.990	-1.225	-0.451	-0.256	1.180	0.351	0.574
DITTMER_PTHLH_TARGETS_DN DITTMER_PTHLH_TARGETS_DN	-1.999	0.342	0.997	0.737	-0.264	-1.999	0.342	0.997	1.636	-1.999	-0.261
LINDSTEDT_DENDRITIC_CELL_MATURATION_D LINDSTEDT_DENDRITIC_CELL_MATURATION_D	0.301	-1.152	-0.301	-1.152	-1.152	-1.712	-0.489	0.301	1.640	2.474	1.290
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN	-0.893	-0.266	-1.575	-0.266	-1.575	-0.500	0.339	2.222	1.278	1.278	-0.498
APPEL_IMATINIB_RESPONSE APPEL_IMATINIB_RESPONSE	-1.367	-0.385	-0.733	-0.733	-1.367	-0.733	0.453	1.130	0.453	0.754	2.677
LANDIS_ERBB2_BREAST_TUMORS_324_DN LANDIS_ERBB2_BREAST_TUMORS_324_DN	-0.975	-1.234	-1.543	1.226	-0.975	-1.543	-0.581	0.659	1.226	1.979	1.467
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	0.324	0.864	0.651	1.692	-1.176	-3.859	0.472	0.324	0.472	0.324	-1.170
FOSTER_TOLERANT_MACROPHAGE_UP FOSTER_TOLERANT_MACROPHAGE_UP	1.330	0.468	-0.608	-0.782	-3.291	-1.241	-0.347	0.355	-0.347	2.992	0.761
KIM_WT1_TARGETS_12HR_UP KIM_WT1_TARGETS_12HR_UP	0.457	-1.556	-0.475	0.457	-1.556	-2.774	-0.356	0.457	0.738	1.534	2.345
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	-0.508	-0.508	-0.786	2.411	-0.786	-1.748	0.459	-0.786	3.381	-0.315	-0.313
SASSON_RESPONSE_TO_GONADOTROPHINS_DN SASSON_RESPONSE_TO_GONADOTROPHINS_DN	-1.005	-0.711	0.595	0.595	-1.901	-2.584	0.419	2.768	0.419	0.595	0.423
HAN_JNK_SINGALING_DN HAN_JNK_SINGALING_DN	-0.283	0.555	-0.525	-0.283	-1.616	0.555	-1.616	-0.925	0.320	0.555	3.294
RODRIGUES_NTN1_AND_DCC_TARGETS RODRIGUES_NTN1_AND_DCC_TARGETS	-1.450	2.478	-0.219	-0.430	-0.796	-1.450	-0.430	-0.430	1.933	-0.219	0.683
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	2.771	-0.702	0.247	-1.326	-0.702	1.647	-0.702	-0.702	-0.702	-0.363	1.189
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	0.784	-1.064	-2.446	-0.434	1.791	1.411	-1.064	-0.691	-0.434	0.346	1.080
SMIRNOV_RESPONSE_TO_IR_6HR_DN SMIRNOV_RESPONSE_TO_IR_6HR_DN	-0.393	2.870	-0.552	1.032	-1.732	-2.843	0.467	0.816	0.467	-0.756	-0.269
LIM_MAMMARY_LUMINAL_PROGENITOR_UP LIM_MAMMARY_LUMINAL_PROGENITOR_UP	2.747	-1.571	-1.035	-1.571	-0.247	-0.416	-0.247	-0.668	0.362	0.362	2.284
ELVIDGE_HIF1A_TARGETS_UP ELVIDGE_HIF1A_TARGETS_UP	-0.910	1.728	0.790	1.375	0.372	-2.820	0.790	0.372	-0.606	-0.910	-0.905
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	-0.392	-1.124	-0.676	-1.865	-0.676	-0.392	0.409	1.320	-0.392	0.654	3.298
LY_AGING_MIDDLE_DN LY_AGING_MIDDLE_DN	-0.663	3.556	1.292	-0.247	-0.663	-0.663	0.362	-0.247	-0.663	-0.247	-0.661
RICKMAN_HEAD_AND_NECK_CANCER_B RICKMAN_HEAD_AND_NECK_CANCER_B	0.910	0.245	-0.949	-0.949	1.601	1.232	-0.365	-2.280	0.637	-1.466	0.641
BROWNE_HCMV_INFECTION_12HR_UP BROWNE_HCMV_INFECTION_12HR_UP	-0.971	1.913	0.664	0.496	-0.253	-2.774	-1.676	1.610	0.859	-0.369	-0.715
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-0.538	1.528	1.231	0.967	-1.077	-1.999	1.528	0.246	0.376	-0.771	-1.991
BASSO_HAIRY_CELL_LEUKEMIA_UP BASSO_HAIRY_CELL_LEUKEMIA_UP	-0.842	0.538	-0.577	0.367	-1.675	-0.842	-1.198	-0.244	0.538	4.726	0.370
VANASSE_BCL2_TARGETS_UP VANASSE_BCL2_TARGETS_UP	-0.341	0.836	-0.341	-0.671	-1.284	-1.284	0.264	-0.341	-0.341	0.264	4.296
HU_GENOTOXIC_DAMAGE_24HR HU_GENOTOXIC_DAMAGE_24HR	1.859	-1.492	-0.453	2.389	-0.453	-1.492	-0.234	-0.234	-0.828	0.646	-0.233
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	-1.381	-0.373	-0.250	0.896	-1.828	-2.399	1.405	1.702	0.507	0.896	-0.533
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	-1.328	0.498	1.055	0.750	-0.513	-2.114	-0.301	2.270	0.750	-0.837	-0.833
PARK_TRETINOIN_RESPONSE PARK_TRETINOIN_RESPONSE	0.166	-0.497	-0.497	-0.497	-0.497	-0.497	-0.497	0.524	-0.497	3.495	1.055
HOLLEMAN_DAUNORUBICIN_B_ALL_DN HOLLEMAN_DAUNORUBICIN_B_ALL_DN	-0.497	-0.497	3.495	0.166	-0.497	-0.497	1.052	0.524	-0.497	-0.497	-0.496
VARELA_ZMPSTE24_TARGETS_DN VARELA_ZMPSTE24_TARGETS_DN	1.477	-0.336	0.269	-1.024	-1.741	-0.336	-1.024	-1.024	0.476	0.749	2.440
WOTTON_RUNX_TARGETS_DN WOTTON_RUNX_TARGETS_DN	-0.610	-0.610	0.572	-0.300	0.572	-1.202	0.572	-1.202	-0.300	-0.610	3.834
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	1.763	0.361	-1.439	-0.486	-1.439	-1.439	-1.819	0.490	1.245	1.245	1.029
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-1.143	1.524	1.249	0.783	-1.514	-2.568	-0.849	1.249	0.783	-0.301	-0.434
WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT	-1.241	0.627	1.876	0.627	-0.546	-2.696	-0.344	0.262	-0.546	-0.546	1.885
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN	-0.906	0.840	1.230	2.549	-0.906	-3.133	0.675	-0.543	0.675	-0.543	-0.701
ALONSO_METASTASIS_EMT_UP ALONSO_METASTASIS_EMT_UP	-0.796	1.030	-0.430	-0.430	-0.219	-1.450	-1.450	-0.430	-0.219	1.933	1.939
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-0.578	0.664	0.664	2.543	-1.431	-2.239	0.664	0.435	0.435	-0.578	-0.916
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	0.262	1.595	0.870	1.886	-3.087	-1.928	0.376	-0.483	0.376	0.262	-0.656
BRACHAT_RESPONSE_TO_METHOTREXATE_UP BRACHAT_RESPONSE_TO_METHOTREXATE_UP	0.772	-0.462	-0.462	-0.994	-0.994	-0.994	-0.994	1.744	0.772	0.772	0.775
BURTON_ADIPOGENESIS_PEAK_AT_24HR BURTON_ADIPOGENESIS_PEAK_AT_24HR	-0.702	3.193	1.271	0.920	-0.702	-0.702	-0.702	-0.228	-0.411	-1.907	-0.226
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	-0.477	0.614	1.788	-0.860	-0.860	-1.533	-1.533	1.332	0.614	-0.250	0.617
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	-1.006	-0.645	-1.006	0.845	-0.645	-2.363	-0.399	0.587	1.151	1.900	0.849
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-2.239	-0.578	-0.578	0.664	-0.921	-0.921	-0.578	2.076	0.435	0.664	1.660
SUNG_METASTASIS_STROMA_DN SUNG_METASTASIS_STROMA_DN	0.258	3.053	2.543	0.258	-1.431	-0.921	-0.348	-0.921	-0.348	-0.921	-0.346
CHANDRAN_METASTASIS_TOP50_DN CHANDRAN_METASTASIS_TOP50_DN	-0.373	0.239	-0.373	0.430	-1.090	-1.824	-0.650	1.798	0.684	2.277	-1.086
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	-0.566	0.250	2.231	1.132	0.405	-1.855	1.132	0.405	-0.359	-1.271	-1.848
BOWIE_RESPONSE_TO_TAMOXIFEN BOWIE_RESPONSE_TO_TAMOXIFEN	-0.746	-0.746	-0.298	-0.746	-0.746	-0.746	0.304	0.304	0.304	2.399	1.717
ZHANG_BREAST_CANCER_PROGENITORS_DN ZHANG_BREAST_CANCER_PROGENITORS_DN	-1.535	1.144	0.438	-0.396	-3.653	-0.719	0.745	1.635	0.580	-0.539	0.751
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	4.139	0.402	-1.100	-2.026	0.660	-0.405	-0.301	-1.362	-0.689	0.402	0.826
BRUINS_UVC_RESPONSE_MIDDLE BRUINS_UVC_RESPONSE_MIDDLE	-1.303	0.558	0.558	1.507	-1.739	-0.962	1.819	0.971	0.558	-0.696	-1.731
BURTON_ADIPOGENESIS_PEAK_AT_0HR BURTON_ADIPOGENESIS_PEAK_AT_0HR	1.593	-0.315	-0.786	-0.508	-1.748	-1.748	-0.786	-0.315	0.675	1.593	1.600
LEE_NEURAL_CREST_STEM_CELL_DN LEE_NEURAL_CREST_STEM_CELL_DN	1.595	0.870	-1.508	-0.661	-0.483	-0.661	-0.885	-0.885	-1.164	1.086	2.916
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.473	-0.313	1.366	2.034	-1.364	-0.981	0.831	1.082	0.435	-1.364	-1.861
MIKKELSEN_ES_HCP_WITH_H3K27ME3 MIKKELSEN_ES_HCP_WITH_H3K27ME3	0.285	-0.574	-0.318	-0.991	1.129	0.783	0.501	-1.699	-1.699	0.285	2.004
MORI_MATURE_B_LYMPHOCYTE_DN MORI_MATURE_B_LYMPHOCYTE_DN	-0.327	3.004	1.119	0.620	-0.327	-2.180	-1.549	0.620	-1.091	-0.327	-0.325
RAMASWAMY_METASTASIS_UP RAMASWAMY_METASTASIS_UP	-0.566	1.825	1.132	1.825	-0.860	-1.855	0.405	0.405	0.250	-1.271	-1.266
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	-0.958	-0.300	-1.658	-0.549	-0.958	1.594	-0.300	-0.300	-0.300	0.527	3.191
SMITH_LIVER_CANCER SMITH_LIVER_CANCER	-1.225	-0.451	2.001	0.571	-0.256	-1.990	1.180	1.180	-1.225	-0.256	-0.449
TERAMOTO_OPN_TARGETS_CLUSTER_7 TERAMOTO_OPN_TARGETS_CLUSTER_7	2.399	-0.746	-0.746	0.655	1.128	-0.298	-0.746	-0.746	-0.746	0.655	-0.297
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	0.501	-0.991	0.501	1.129	-0.574	-1.699	-0.574	0.501	-1.699	1.534	0.787
LIN_MELANOMA_COPY_NUMBER_DN LIN_MELANOMA_COPY_NUMBER_DN	-0.991	1.129	0.501	1.129	-1.699	-1.699	0.783	0.285	0.285	0.783	-0.987
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	0.576	-2.603	-1.167	0.576	-2.009	1.220	-0.312	0.762	-0.634	1.220	0.983
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-0.651	0.405	-0.323	0.559	-1.567	-2.637	-0.889	0.405	1.191	2.789	0.409
BENPORATH_ES_CORE_NINE_CORRELATED BENPORATH_ES_CORE_NINE_CORRELATED	0.707	3.659	0.707	-0.733	0.249	-2.365	0.524	0.371	-1.006	-0.521	-1.000
BOYLAN_MULTIPLE_MYELOMA_PCA3_DN BOYLAN_MULTIPLE_MYELOMA_PCA3_DN	-0.406	-0.935	-0.406	-0.252	-0.935	-1.963	-0.406	-0.252	-0.252	2.939	2.495
CHIBA_RESPONSE_TO_TSA CHIBA_RESPONSE_TO_TSA	-0.676	-0.676	0.409	0.409	-1.124	-1.865	-0.676	0.958	3.288	0.226	0.412
FARMER_BREAST_CANCER_CLUSTER_4 FARMER_BREAST_CANCER_CLUSTER_4	0.279	-0.787	-0.787	-0.787	-0.787	-0.324	-0.324	-0.324	0.279	2.269	2.275
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-0.260	2.675	0.347	1.503	-0.260	-1.119	-0.550	-0.260	0.347	-1.119	-1.116
ENGELMANN_CANCER_PROGENITORS_UP ENGELMANN_CANCER_PROGENITORS_UP	0.848	-0.755	-0.256	1.565	-1.990	-0.755	0.351	-1.225	-0.755	0.848	1.572
HU_ANGIOGENESIS_DN HU_ANGIOGENESIS_DN	-0.250	3.503	0.359	1.332	-0.250	-0.860	-0.250	-0.250	-1.533	-0.860	-0.857
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4 PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	0.280	-0.465	-0.889	-3.409	-0.651	-0.323	-0.465	0.741	0.405	1.458	2.431
BAUS_TFF2_TARGETS_UP BAUS_TFF2_TARGETS_UP	-1.367	-0.733	-1.367	0.231	0.754	1.130	0.453	0.231	0.453	1.577	-1.364
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	1.516	0.339	-0.412	-0.412	-1.253	-3.360	-0.412	0.339	-0.266	0.937	1.524
FAELT_B_CLL_WITH_VH3_21_DN FAELT_B_CLL_WITH_VH3_21_DN	-1.259	0.814	-0.271	2.929	-0.271	-2.031	0.334	0.814	-0.782	0.334	-0.779
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-0.541	1.350	2.875	0.578	-0.541	-2.253	0.578	0.253	-0.355	-0.541	-1.605
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	0.691	1.254	-3.102	-0.693	-0.399	1.046	-1.731	-0.531	-0.399	0.691	1.742
GNATENKO_PLATELET_SIGNATURE GNATENKO_PLATELET_SIGNATURE	-0.373	-1.090	-0.373	-1.090	-0.373	-0.373	0.430	1.798	2.277	0.684	-1.819
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	0.371	-0.520	-1.077	-1.077	1.578	1.088	0.371	-0.520	-0.520	-1.077	1.583
LI_AMPLIFIED_IN_LUNG_CANCER LI_AMPLIFIED_IN_LUNG_CANCER	-0.513	-0.392	-0.660	1.177	-0.293	-1.901	2.114	1.385	1.177	-1.044	-1.889
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	-0.508	0.675	0.459	0.288	-1.748	-2.613	1.244	-0.315	0.938	1.244	-0.782
LANDIS_ERBB2_BREAST_TUMORS_65_UP LANDIS_ERBB2_BREAST_TUMORS_65_UP	-0.911	0.217	-0.911	1.932	-0.406	-0.911	-0.406	0.490	0.873	-0.911	1.361
LUCAS_HNF4A_TARGETS_UP LUCAS_HNF4A_TARGETS_UP	-0.247	0.564	1.844	-0.416	-1.571	-1.571	0.814	-1.571	1.456	0.564	-0.664
DELASERNA_MYOD_TARGETS_UP DELASERNA_MYOD_TARGETS_UP	-0.326	-0.326	1.644	-1.901	-1.392	-0.489	-0.711	0.419	-0.711	3.203	0.600
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	1.083	0.476	-1.741	-1.741	-0.336	0.269	-0.336	-0.599	-0.599	1.083	1.935
WANG_CISPLATIN_RESPONSE_AND_XPC_UP WANG_CISPLATIN_RESPONSE_AND_XPC_UP	0.620	3.198	1.315	0.932	-1.347	-1.347	-0.318	-0.882	-1.637	-0.548	0.288
BURTON_ADIPOGENESIS_11 BURTON_ADIPOGENESIS_11	-0.837	0.750	1.055	1.055	-1.328	-2.114	1.412	-0.837	-0.301	0.750	-0.510
NADLER_OBESITY_UP NADLER_OBESITY_UP	-0.452	-1.093	-0.715	-2.488	-0.274	-0.715	-0.274	0.756	1.039	1.739	1.374
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	-0.870	0.236	-0.870	-0.870	0.527	4.352	-0.378	0.236	-0.378	0.236	-0.377
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	0.291	-0.443	-1.099	1.163	-1.432	-2.982	0.413	0.413	0.291	2.326	0.741
TAVOR_CEBPA_TARGETS_UP TAVOR_CEBPA_TARGETS_UP	-0.316	-0.316	-0.535	-0.316	-1.362	-2.156	-0.865	0.720	1.364	1.761	1.022
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	0.217	2.594	0.873	0.873	-0.911	-0.911	0.217	-0.911	0.217	-0.911	-0.404
DAIRKEE_CANCER_PRONE_RESPONSE_BPA DAIRKEE_CANCER_PRONE_RESPONSE_BPA	-0.513	2.767	2.270	0.301	-0.837	-1.328	0.498	-0.513	-0.301	-1.328	-0.510
SMID_BREAST_CANCER_LUMINAL_A_DN SMID_BREAST_CANCER_LUMINAL_A_DN	-0.298	3.182	1.128	-0.298	0.655	-0.746	-0.298	-0.298	-0.746	-0.746	-0.744
CROMER_METASTASIS_UP CROMER_METASTASIS_UP	-2.107	0.301	0.906	1.187	-0.710	-2.107	0.463	0.664	-1.038	1.507	0.304
HUI_MAPK14_TARGETS_UP HUI_MAPK14_TARGETS_UP	1.521	-0.828	-0.351	-0.351	-0.828	-0.351	-0.828	-0.828	0.256	1.521	1.525
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	-0.399	-1.006	1.151	1.151	0.379	-2.363	0.379	1.503	0.379	-0.399	-1.531
GENTILE_UV_RESPONSE_CLUSTER_D6 GENTILE_UV_RESPONSE_CLUSTER_D6	0.680	0.403	0.403	1.933	0.680	-1.450	0.403	-1.450	-0.219	-0.430	-1.446
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-0.348	-0.578	-0.578	1.274	0.664	-1.431	3.053	0.664	-0.348	-0.921	-1.426
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.406	-1.363	-1.963	-0.252	0.357	3.950	0.763	-0.935	0.357	-0.252	-0.249
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	-1.051	-0.260	1.372	0.346	-2.432	-1.407	-0.260	2.334	-0.771	0.667	0.672
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	1.190	-0.622	0.397	-2.322	0.397	0.397	-0.977	-1.501	0.397	0.397	1.965
FURUKAWA_DUSP6_TARGETS_PCI35_UP FURUKAWA_DUSP6_TARGETS_PCI35_UP	0.463	-1.038	-1.038	-0.710	-1.486	0.664	-0.710	-0.301	-0.301	1.187	3.643
ROESSLER_LIVER_CANCER_METASTASIS_UP ROESSLER_LIVER_CANCER_METASTASIS_UP	-0.301	2.892	-0.438	1.524	-0.849	-1.979	-1.143	-0.849	0.432	1.002	-0.434
LAU_APOPTOSIS_CDKN2A_UP LAU_APOPTOSIS_CDKN2A_UP	-0.600	0.910	0.245	1.601	-1.466	-2.280	0.245	1.232	0.245	0.637	-0.945
SENGUPTA_EBNA1_ANTICORRELATED SENGUPTA_EBNA1_ANTICORRELATED	-0.409	-1.143	-0.707	-0.409	-2.144	-1.424	-0.301	1.025	1.230	1.964	1.467
FARMER_BREAST_CANCER_CLUSTER_5 FARMER_BREAST_CANCER_CLUSTER_5	-0.787	0.609	0.279	0.279	0.279	-0.787	1.057	2.269	-0.787	-0.787	-0.785
LIU_CDX2_TARGETS_DN LIU_CDX2_TARGETS_DN	-0.331	-0.331	0.273	-0.331	-0.331	4.874	-0.331	0.273	-0.331	-0.331	-0.330
WEBER_METHYLATED_ICP_IN_FIBROBLAST WEBER_METHYLATED_ICP_IN_FIBROBLAST	0.236	-0.870	-0.870	-0.870	0.930	0.527	0.930	-0.870	-0.870	0.930	0.933
ZHENG_IL22_SIGNALING_UP ZHENG_IL22_SIGNALING_UP	0.784	-1.606	-0.434	-0.434	-0.691	0.784	-1.064	-0.434	-1.064	2.676	1.418
MORI_PLASMA_CELL_UP MORI_PLASMA_CELL_UP	-0.332	-0.893	-0.332	-0.556	-0.893	-1.397	0.691	3.135	1.706	0.272	-0.888
FU_INTERACT_WITH_ALKBH8 FU_INTERACT_WITH_ALKBH8	-0.538	0.967	0.476	3.261	-0.538	-0.538	-0.538	-0.176	-0.176	-0.538	-0.537
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	0.217	1.932	1.356	0.873	0.217	-0.911	0.217	-0.911	-0.911	-0.406	-0.909
LIU_CMYB_TARGETS_UP LIU_CMYB_TARGETS_UP	0.276	-0.752	-1.490	0.965	-0.957	-2.686	0.276	1.615	1.379	1.162	-0.324
INGRAM_SHH_TARGETS_UP INGRAM_SHH_TARGETS_UP	0.594	1.191	-0.282	-0.744	-3.263	-0.983	-0.552	0.768	-0.744	1.440	1.200
HEDENFALK_BREAST_CANCER_BRACX_DN HEDENFALK_BREAST_CANCER_BRACX_DN	-0.828	-0.351	0.991	2.148	-0.351	-0.828	-0.828	0.991	0.566	-0.828	-0.350
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-1.091	-0.327	0.620	0.428	-0.506	-3.111	-0.327	-0.506	0.428	1.426	1.778
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-0.522	0.256	0.390	-0.351	-0.751	-1.966	0.390	4.510	0.557	-0.351	-1.047
MADAN_DPPA4_TARGETS MADAN_DPPA4_TARGETS	1.367	0.519	-0.452	-1.642	0.519	0.519	-0.452	-0.715	-2.488	0.519	1.374
LIU_SMARCA4_TARGETS LIU_SMARCA4_TARGETS	1.461	-0.810	-0.285	-0.810	-0.810	-0.810	-0.492	-0.285	0.521	-0.810	4.004
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.704	-0.704	-0.272	-0.704	-0.704	-0.704	0.332	1.206	-0.272	1.821	1.210
NIKOLSKY_BREAST_CANCER_17P11_AMPLICON NIKOLSKY_BREAST_CANCER_17P11_AMPLICON	0.640	0.211	-0.414	-0.414	-0.414	-0.414	0.211	-0.414	4.069	-0.414	-0.413
GHANDHI_DIRECT_IRRADIATION_UP GHANDHI_DIRECT_IRRADIATION_UP	1.279	0.611	-1.949	-0.601	-1.949	0.447	-0.601	-0.829	-0.291	1.558	1.568
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	0.763	-0.921	-0.921	-0.526	-0.921	-1.899	-0.921	1.666	0.954	2.252	0.456
CHEOK_RESPONSE_TO_HD_MTX_UP CHEOK_RESPONSE_TO_HD_MTX_UP	0.199	-0.953	-0.953	0.199	0.199	0.457	-0.953	-0.434	0.199	0.199	3.989
BURTON_ADIPOGENESIS_8 BURTON_ADIPOGENESIS_8	0.538	-0.842	-0.842	-1.198	-0.842	-1.675	0.748	1.277	1.949	1.277	-0.573
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN	0.502	1.209	-0.888	-0.888	-0.614	-0.888	-1.739	-0.614	0.701	0.502	3.084
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-1.296	0.391	-0.442	2.703	-0.442	-3.093	0.283	1.051	0.676	-0.594	0.396
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.273	-0.963	-0.727	-0.727	-1.254	-2.043	0.788	0.458	0.458	2.045	2.057
RIEGE_DELTANP63_DIRECT_TARGETS_UP RIEGE_DELTANP63_DIRECT_TARGETS_UP	-0.553	2.177	0.727	0.912	-1.231	-2.994	-0.735	0.426	-0.407	1.120	-0.403
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	1.245	-1.439	-0.867	-1.439	-0.656	-0.656	0.490	-0.486	-0.352	1.245	3.079
YAGI_AML_SURVIVAL YAGI_AML_SURVIVAL	-0.710	0.808	1.500	-0.377	-1.584	-3.192	-0.264	-0.377	0.808	1.244	0.476
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-1.669	0.301	3.074	1.639	0.402	-2.026	0.402	-0.405	-0.301	-0.405	-0.869
BROWNE_HCMV_INFECTION_24HR_DN BROWNE_HCMV_INFECTION_24HR_DN	0.469	-0.652	-1.731	0.348	-1.731	-0.652	-0.851	0.348	0.469	2.224	2.237
EHRLICH_ICF_SYNDROM_DN EHRLICH_ICF_SYNDROM_DN	-0.704	-0.704	-0.704	-0.704	1.821	0.332	0.332	-0.272	0.332	-0.704	1.826
